Model-informed intermittent tenofovir disoproxil fumarate and emtricitabine dosing for HIV pre-exposure prophylaxis in subjects with renal impairment: a case report

被引：2
|
作者：
Zino, Leena [1 ,3 ]
Jacobs, Tom G. [1 ]
Nieuwenstein, Thomas [1 ]
Grintjes, Karin [2 ]
Colbers, Angela [1 ]
Burger, David M. [1 ]
机构：
[1] Radboud Univ Nijmegen, Radboud Inst Hlth Sci, Dept Pharm, Med Ctr, Nijmegen, Netherlands
[2] Radboud Univ Nijmegen, Radboud Inst Hlth Sci, Dept Internal Med, Med Ctr, Nijmegen, Netherlands
[3] Radboud Univ Nijmegen, Radboud Inst Hlth Sci, Dept Pharm, Med Ctr, 864 Radbou dumc,Geert Grooteplein 10, NL-6525 GA Nijmegen, Netherlands
来源：
AIDS | 2023年 / 37卷 / 02期
关键词：
KIDNEY-FUNCTION; EXPOSURE;
D O I：
10.1097/QAD.0000000000003438
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：363 / 365
页数：3
相关论文
共 50 条
  • [21] Safety of oral tenofovir disoproxil fumarate-based pre-exposure prophylaxis for HIV prevention
    Mugwanya, Kenneth K.
    Baeten, Jared M.
    [J]. EXPERT OPINION ON DRUG SAFETY, 2016, 15 (02) : 265 - 273
  • [22] Daily HIV pre-exposure prophylaxis (PrEP) with tenofovir disoproxil fumarate-emtricitabine reduced Streptococcus and increased Erysipelotrichaceae in rectal microbiota
    Dube, Michael P.
    Park, Sung Yong
    Ross, Heather
    Love, Tanzy M. T.
    Morris, Sheldon R.
    Lee, Ha Youn
    [J]. SCIENTIFIC REPORTS, 2018, 8
  • [23] Daily HIV pre-exposure prophylaxis (PrEP) with tenofovir disoproxil fumarate-emtricitabine reduced Streptococcus and increased Erysipelotrichaceae in rectal microbiota
    Michael P. Dubé
    Sung Yong Park
    Heather Ross
    Tanzy M. T. Love
    Sheldon R. Morris
    Ha Youn Lee
    [J]. Scientific Reports, 8
  • [24] Review of Real-World Implementation Data on Emtricitabine-Tenofovir Disoproxil Fumarate as HIV Pre-exposure Prophylaxis in the United States
    Adams, Jessica L.
    Shelley, Karishma
    Nicol, Melanie R.
    [J]. PHARMACOTHERAPY, 2019, 39 (04): : 486 - 500
  • [25] Emtricitabine/tenofovir disoproxil fumarate in HIV-1 pre-exposure prophylaxis: a guide to its once-daily use in the EU
    Deeks E.D.
    Lyseng-Williamson K.
    Plosker G.L.
    [J]. Drugs & Therapy Perspectives, 2017, 33 (1) : 8 - 15
  • [26] Pill related oesophagitis due to tenofovir disproxil fumarate/emtricitabine (Truvada) HIV pre-exposure prophylaxis
    Bonnichsen, Mark H.
    Tschuchnigg, Mark
    Post, Jeffrey J.
    Bye, William
    [J]. INTERNAL MEDICINE JOURNAL, 2022, 52 (06) : 1099 - 1100
  • [27] Pre-exposure prophylaxis for HIV with oral tenofovir disoproxil fumarate/emtricitabine in men who have sex with men: Slovenian national demonstration project
    Pecavar, Blaz
    Kokosar Ulcar, Barbara
    Kordis, Manja
    Plesko, Maja
    Turel, Gabriele
    Vovko, Tomaz
    Tomazic, Janez
    [J]. INTERNATIONAL JOURNAL OF STD & AIDS, 2021, 32 (11) : 1060 - 1065
  • [28] Trends in the use of oral emtricitabine/tenofovir disoproxil fumarate for pre-exposure prophylaxis against HIV infection, United States, 2012-2017
    Sullivan, Patrick S.
    Giler, Robertino Mera
    Mouhanna, Farah
    Pembleton, Elizabeth S.
    Jones, Jeb
    Castel, Amanda D.
    Yeung, Howa
    Kramer, Michael
    McCallister, Scott
    Siegler, Aaron J.
    [J]. ANNALS OF EPIDEMIOLOGY, 2018, 28 (12) : 833 - 840
  • [29] Changes in kidney function among men having sex with men starting on demand tenofovir disoproxil fumarate - emtricitabine for HIV pre-exposure prophylaxis
    Liegeon, Geoffroy
    Antoni, Guillemette
    Pialoux, Gilles
    Capitant, Catherine
    Cotte, Laurent
    Charreau, Isabelle
    Tremblay, Cecile
    Cua, Eric
    Senneville, Eric
    Raffi, Francois
    Meyer, Laurence
    Molina, Jean-Michel
    [J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2020, 23 (02)
  • [30] HIV prevention: response to pre-exposure prophylaxis failure with tenofovir disoproxil
    Fox, Julie
    Collins, Simon
    [J]. AIDS, 2017, 31 (09) : 1343 - 1343
12345